OPKO Health, Inc. - Product Pipeline Review - 2016

  • ID: 3734743
  • Company Profile
  • 81 pages
  • Global Markets Direct
  • OPKO Health Inc
1 of 4
OPKO Health, Inc. - Product Pipeline Review - 2016

Summary

‘OPKO Health, Inc. - Product Pipeline Review - 2016’, provides an overview of the OPKO Health, Inc.’s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by OPKO Health, Inc., complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Our report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

- The report provides a snapshot of the pipeline therapeutic landscape of OPKO Health, Inc.
- The report provides overview of OPKO Health, Inc. including its business description, key facts, and locations and subsidiaries
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- The report assesses OPKO Health, Inc.’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
- The report features OPKO Health, Inc.’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons to buy

- Evaluate OPKO Health, Inc.’s strategic position with total access to detailed information on its product pipeline
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of therapeutics under development for OPKO Health, Inc.
- Identify potential new clients or partners in the target demographic
- Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding OPKO Health, Inc.’s pipeline depth and focus of pipeline therapeutics
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
READ MORE
Note: Product cover images may vary from those shown
2 of 4
List of Tables

List of Figures

OPKO Health, Inc. Snapshot

OPKO Health, Inc. Overview

Key Information

Key Facts

OPKO Health, Inc. - Research and Development Overview

Key Therapeutic Areas

OPKO Health, Inc. - Pipeline Review

Pipeline Products by Stage of Development

Pipeline Products - Monotherapy

Pipeline Products - Combination Treatment Modalities

Pipeline Products - Out-Licensed Products

Out-Licensed Products/Combination Treatment Modalities

OPKO Health, Inc. - Pipeline Products Glance

OPKO Health, Inc. - Late Stage Pipeline Products

Filing rejected/Withdrawn Products/Combination Treatment Modalities

Phase III Products/Combination Treatment Modalities

OPKO Health, Inc. - Clinical Stage Pipeline Products

Phase II Products/Combination Treatment Modalities

Phase I Products/Combination Treatment Modalities

OPKO Health, Inc. - Early Stage Pipeline Products

Preclinical Products/Combination Treatment Modalities

Discovery Products/Combination Treatment Modalities

OPKO Health, Inc. - Unknown Stage Pipeline Products

Unknown Products/Combination Treatment Modalities

OPKO Health, Inc. - Drug Profiles

calcifediol MR

Product Description

Mechanism of Action

R&D Progress

fermagate

Product Description

Mechanism of Action

R&D Progress

MOD-4023

Product Description

Mechanism of Action

R&D Progress

CTAP-201

Product Description

Mechanism of Action

R&D Progress

lunacalcipol

Product Description

Mechanism of Action

R&D Progress

MOD-5014

Product Description

Mechanism of Action

R&D Progress

MOD-6031

Product Description

Mechanism of Action

R&D Progress

CTA-091

Product Description

Mechanism of Action

R&D Progress

CUR-1916

Product Description

Mechanism of Action

R&D Progress

Drugs to Inhibit CYP24 for Secondary Hyperparathyroidism, Chronic Kidney Disease and Oncology

Product Description

Mechanism of Action

R&D Progress

influenza [strains A/H1N1 + A/H3N2 + A/H5N1] vaccine

Product Description

Mechanism of Action

R&D Progress

MOD-1001

Product Description

Mechanism of Action

R&D Progress

MOD-1002

Product Description

Mechanism of Action

R&D Progress

MOD-6030

Product Description

Mechanism of Action

R&D Progress

MOD-7023

Product Description

Mechanism of Action

R&D Progress

MOD-9013

Product Description

Mechanism of Action

R&D Progress

MOD-9017

Product Description

Mechanism of Action

R&D Progress

Oligonucleotide for Mucopolysaccharidosis I

Product Description

Mechanism of Action

R&D Progress

Oligonucleotide For Rett Syndrome

Product Description

Mechanism of Action

R&D Progress

Small Molecule for Hearing Loss

Product Description

Mechanism of Action

R&D Progress

Small Molecule for Oncology

Product Description

Mechanism of Action

R&D Progress

Small Molecules to Inhibit Phosphate Transport for Hyperphosphatemia In CKD

Product Description

Mechanism of Action

R&D Progress

SR-3306

Product Description

Mechanism of Action

R&D Progress

Recombinant Protein for Atherosclerosis

Product Description

Mechanism of Action

R&D Progress

Recombinant Protein for Rheumatoid Arthritis

Product Description

Mechanism of Action

R&D Progress

Small Molecules to Inhibit Lipoprotein Signal Peptidase for Bacterial Infections

Product Description

Mechanism of Action

R&D Progress

OPK-0018

Product Description

Mechanism of Action

R&D Progress

OPKO Health, Inc. - Pipeline Analysis

OPKO Health, Inc. - Pipeline Products by Target

OPKO Health, Inc. - Pipeline Products by Route of Administration

OPKO Health, Inc. - Pipeline Products by Molecule Type

OPKO Health, Inc. - Pipeline Products by Mechanism of Action

OPKO Health, Inc. - Recent Pipeline Updates

OPKO Health, Inc. - Dormant Projects

OPKO Health, Inc. - Company Statement

OPKO Health, Inc. - Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Appendix

Methodology

Coverage

Secondary Research

Primary Research

Expert Panel Validation

Contact Us

Disclaimer

List of Tables

OPKO Health, Inc., Key Information

OPKO Health, Inc., Key Facts

OPKO Health, Inc. - Pipeline by Indication, 2016

OPKO Health, Inc. - Pipeline by Stage of Development, 2016

OPKO Health, Inc. - Monotherapy Products in Pipeline, 2016

OPKO Health, Inc. - Combination Treatment Modalities in Pipeline, 2016

OPKO Health, Inc. - Out-Licensed Products in Pipeline, 2016

OPKO Health, Inc. - Out-Licensed Products/ Combination Treatment Modalities, 2016

OPKO Health, Inc. - Filing rejected/Withdrawn, 2016

OPKO Health, Inc. - Phase III, 2016

OPKO Health, Inc. - Phase II, 2016

OPKO Health, Inc. - Phase I, 2016

OPKO Health, Inc. - Preclinical, 2016

OPKO Health, Inc. - Discovery, 2016

OPKO Health, Inc. - Unknown, 2016

OPKO Health, Inc. - Pipeline by Target, 2016

OPKO Health, Inc. - Pipeline by Route of Administration, 2016

OPKO Health, Inc. - Pipeline by Molecule Type, 2016

OPKO Health, Inc. - Pipeline Products by Mechanism of Action, 2016

OPKO Health, Inc. - Recent Pipeline Updates, 2016

OPKO Health, Inc. - Dormant Developmental Projects,2016

OPKO Health, Inc., Subsidiaries

List of Figures

OPKO Health, Inc. - Pipeline by Top 10 Indication, 2016

OPKO Health, Inc. - Pipeline by Stage of Development, 2016

OPKO Health, Inc. - Monotherapy Products in Pipeline, 2016

OPKO Health, Inc. - Out-Licensed Products in Pipeline, 2016

OPKO Health, Inc. - Pipeline by Top 10 Target, 2016

OPKO Health, Inc. - Pipeline by Route of Administration, 2016

OPKO Health, Inc. - Pipeline by Molecule Type, 2016

OPKO Health, Inc. - Pipeline Products by Top 10 Mechanism of Action, 2016
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
Note: Product cover images may vary from those shown
Adroll
adroll